Author

T. Hemmi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Ainai· 1 shared A. Ueno· 1 shared H. Hasegawa· 1 shared K. Sano· 1 shared K. Tamura· 1 shared M. Tobiume· 1 shared N. Iwata-Yoshikawa· 1 shared N. Nagata· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ainai

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

T. Hemmi, A. Ainai, T. Hashiguchi, M. Tobiume, T. Kanno, N. Iwata-Yoshikawa, S. Iida, Y. Sato, S. Miyamoto, A. Ueno, K. Sano, S. Saito, N. Shiwa-Sudo, N. Nagata, K. Tamura, , T. Suzuki

This study shows that an intranasal vaccine with CpG ODN2006 induces secretory IgA antibodies against SARS-CoV-2 variants and reduces lung eosinophilic immunopathology compared to subcutaneous vaccination.

bioRxiv · May 24, 2022Microbiology